MedPath

Transcultural Validation in French of the Systemic Lupus Activity Questionnaire (SLAQ) and the Lupus Quality Of Life (LupusQoL) Questionnaire

Completed
Conditions
Lupus
Registration Number
NCT02857452
Lead Sponsor
Centre Hospitalier Universitaire Dijon
Brief Summary

The evaluation of lupus patients must include several approaches, in particular disease activity and quality of life.

The Systemic Lupus Activity Questionnaire (SLAQ) is a validated self-questionnaire to evaluate disease activity. It has the advantage of being inexpensive, easy to use in large cohorts and has been used in several studies. It has never been validated in French. The Lupus Quality Of Life (LupusQoL) is a self-questionnaire to evaluate quality of life and is specific to systemic lupus erythematous; it was developed from interviews with patients.

This tool, validated in a British population, has never been validated in French.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
162
Inclusion Criteria
  • Patients with lupus meeting the 1997 classification criteria of the American College of Rheumatology for systemic lupus erythematous.
  • Patients able to understand written and spoken French.
  • Patients who have been informed about the research
Exclusion Criteria
  • Severe mental retardation.
  • Any impairment of ability to understand making self-evaluation impossible.
  • Age < 18 years.
  • Age > 75 years.

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Answers in French to the au Systemic Lupus Activity Questionnaire (SLAQ)Evolution of answers between D0, D15, M3 and M6
Secondary Outcome Measures
NameTimeMethod
Answers in French to the Lupus Quality of Life (Lupus QoL) questionnaireEvolution of answers between D0, D15, M3 and M6

Trial Locations

Locations (1)

CHU Dijon Bourgogne

🇫🇷

Dijon, France

CHU Dijon Bourgogne
🇫🇷Dijon, France

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.